These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15538956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.
    Kugelberg FC, Kingbäck M, Carlsson B, Druid H.
    J Anal Toxicol; 2005; 29(4):223-8. PubMed ID: 15975250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
    Wikell C, Apelqvist G, Carlsson B, Hjorth S, Bergqvist PB, Kugelberg FC, Ahlner J, Bengtsson F.
    Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
    Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P.
    Biochem Pharmacol; 1998 Jul 01; 56(1):15-23. PubMed ID: 9698084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC.
    Rochat B, Amey M, Van Gelderen H, Testa B, Baumann P.
    Chirality; 1995 Jul 01; 7(6):389-95. PubMed ID: 7577348
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
    Reis M, Lundmark J, Bengtsson F.
    Ther Drug Monit; 2003 Apr 01; 25(2):183-91. PubMed ID: 12657912
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
    Unceta N, Goicolea MA, Barrio RJ.
    Biomed Chromatogr; 2011 Jan 01; 25(1-2):238-57. PubMed ID: 21058412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
    Reis M, Olsson G, Carlsson B, Lundmark J, Dahl ML, Wålinder J, Ahlner J, Bengtsson F.
    J Clin Psychopharmacol; 2002 Aug 01; 22(4):406-13. PubMed ID: 12172341
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    Foglia JP, Pollock BG, Kirshner MA, Rosen J, Sweet R, Mulsant B.
    Psychopharmacol Bull; 1997 Aug 01; 33(1):109-12. PubMed ID: 9133760
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats.
    Rocha A, Coelho EB, Lanchote VL.
    Can J Physiol Pharmacol; 2008 Nov 01; 86(11):770-6. PubMed ID: 19011672
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.